In February 2026, the outbreak of the conflict involving the US, Israel, and Iran sent shockwaves through the global economy. The sudden closure of the Strait of Hormuz-the world’s most critical maritime energy corridor-disrupted everything from shipping lanes to petrochemical access, leaving European manufacturer networks highly exposed. In Ireland, a nation whose economy is deeply anchored by the export of high-value life science and pharmaceutical products, the sudden price spikes in energy, raw reagents, and air freight created severe operational challenges.
However, the US-Iran deal signed on 18 June 2026 signals a turning point. As the Strait of Hormuz prepares to reopen, the Irish pharmaceutical sector, which exported €138.6 billion of medical and pharmaceutical products in 2025 according to the CSO, stands to experience a series of profound structural benefits. Here is a detailed breakdown of how this international diplomatic resolution will impact Ireland’s biopharma hubs in Cork, Dublin, and Galway over the coming months.
Update, 2 November 2026: The June agreement later collapsed. As of 5 August 2026 the Strait of Hormuz remained effectively closed, according to a report carried by The Philadelphia Inquirer, so the benefits described below had not materialised at that date.
1. Relief on Active Pharmaceutical Ingredient (API) Synthesis Costs
Irish pharmaceutical manufacturing is highly energy-intensive. Large-scale chemical synthesis for APIs and advanced biological drug substances requires massive, uninterrupted electricity and natural gas consumption. By 19 March, the UK benchmark gas price had reached around 157p per therm, up from below 80p before the war, according to the BBC. This surge directly translated into higher utility bills for manufacturing plants operated by multinationals throughout Ireland.
With the UK benchmark gas price back at around 98p per therm after the deal, according to the BBC, operating margins for Irish API facilities are set to stabilize. The reduction in energy overheads will relieve cost pressures on high-volume manufacturing sites, allowing companies to reallocate capital toward process optimization and sustainability upgrades.
2. Normalization of Cold-Chain Logistics and Shipping Corridors
Biologics, vaccines, and monoclonal antibodies produced in Ireland are highly temperature-sensitive, relying on seamless, temperature-controlled "cold-chain" logistics. The closure of the Strait of Hormuz disrupted shipping, and jet fuel prices rose from about $784 a tonne to $1,838 in the weeks after the war began, according to the BBC. This inflated air freight costs for time-critical clinical trial materials and finished medicines.
By mid-June, jet fuel prices had fallen to around $967 a tonne, according to the BBC, which should ease air cargo surcharges and restore the predictability of global supply chains for Irish exporters.
3. Stabilization of Raw Chemical Reagents and Solvent Prices
The global pharmaceutical supply chain relies heavily on petrochemical derivatives, solvents, and specialty chemical reagents. Because the Gulf is a major source of oil and gas exports, the conflict put pressure on the cost of petrochemical inputs used in chemical synthesis, which can raise the cost of goods sold (COGS).
As Middle Eastern oil production and shipping return to regular schedules, the prices of crude oil and natural gas liquids (NGLs) are projected to drift lower. This will stabilize the pricing of solvents and organic chemical intermediaries, easing input costs for Irish chemical synthesis plants.
4. Rebound in Multinational Capital Expenditures (CapEx)
The heightened macroeconomic uncertainty during the four-month conflict may have made some global pharmaceutical companies more cautious about new capital investment while they waited for clarity on inflation and interest rates.
If lower energy prices hold, the outlook for inflation and interest rates may stabilise, which could unlock deferred Capital Expenditure (CapEx) pipelines. Ireland, with its favorable regulatory environment, skilled talent pool, and established manufacturing clusters, is well-positioned to capture these renewed multinational investment flows.
5. Increased Focus on Supply Chain Resilience
While the US-Iran peace agreement has brought immediate relief, the conflict has left a lasting impression on pharmaceutical executives. The sudden vulnerability of key shipping corridors highlighted the risks of concentrated global value chains. In response, both industry leaders and regulatory bodies are expected to accelerate efforts to build redundancy into their operations.
This shift toward supply chain resilience will likely lead to increased localized storage of critical raw materials, broader diversification of API suppliers, and strategic investments in European-based manufacturing capacity. For Ireland, this presents an opportunity to secure its role as a stable, highly resilient hub for global pharmaceutical innovation and production.
Frequently Asked Questions
How does political stability in the Middle East affect shipping?
Stable trade lanes such as the Strait of Hormuz can lower shipping insurance costs and reduce transit delays.
Why is Ireland vulnerable to logistics delays?
Ireland is an island nation reliant on global air and sea shipping networks to import pharmaceutical raw materials and export finished medicines.
What is dual-sourcing in pharmaceutical supply chains?
It is the practice of procuring active ingredients from multiple geographical regions to prevent single-point-of-failure supply disruptions.
Logistics Planning and Supply Chain Safety
A reduction in geopolitical shipping risks allows biopharma logistics managers to optimize transit times and cut holding costs for raw materials. However, to maintain GxP compliance and Good Distribution Practice (GDP) standards, companies must continue to implement multi-layered logistics backup strategies. Investing in robust temperature-controlled shipping solutions remains crucial to protect sensitive biologic therapeutics.
Correction, 2 November 2026: We attributed the energy and jet fuel figures to the BBC and the export figure to the CSO, removed an unattributed quote and unsupported claims about rerouting, Asian trade routes, central banks and deferred investment, and added an update that the June deal later collapsed.
